BioThrax

Anthrax vaccine
Manufacturing

FDA signs off on Emergent's anthrax vaccine Cyfendus

Four years after Emergent began supplying its anthrax vaccine to the U.S., it has been fully approved by the FDA and branded as Cyfendus.
Kevin Dunleavy Jul 21, 2023 10:49am
Emergent BioSolutions Bayview plant

Emergent's founder will retire April 1

Jan 14, 2022 11:45am
merger and acquisition

Acquisitive Emergent BioSolutions buys PaxVax for $270M

Aug 13, 2018 12:25pm
newspapers

Dynavax, Emergent and more—News of Note

Aug 8, 2018 7:59am
non

GSK's Mosquirix, Emergent BioSolutions and more—News of Note

Apr 18, 2018 9:57am